VEGF binding to VEGFR2 leads to activating and translocating RAC1 into the plasma membrane, whereas ROS-dependent signaling events may trigger angiogenesis (i.e., cell migration and proliferation) and influence MMP2, which affect growth factor, tumor promoter stimulation, and prognostic survival as well. This evidence concerns the gene VEGFA and neoplasm.